Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1998-9-17
|
pubmed:abstractText |
This study was designed to determine if adenoviral-mediated delivery of a transgene encoding the beta 2-adrenergic receptor (beta 2-AR) to the carotid arterial wall could result in alterations in in vivo vascular function. De-endothelialized rat carotid arteries were infused in vivo with 0.1 mg/ml elastase and adenovirus [6 x 10(9) plaque forming units (PFU)] containing either the marker gene beta-galactosidase (Adeno-beta-gal), DNA encoding the human beta 2-AR (Adeno-beta 2-AR), or no transgene. This low concentration of elastase increased the water permeability (5.2 +/- 0.6 v 1.9 +/- 0.4 x 10(-8) cm/s/mmHg, n = 4, P < 0.0001) without affecting either the vasomotor responsiveness or the morphology of the arterial wall. A transfection efficiency of 73% was achieved with Adeno-beta-gal (n = 3). beta-gal expression was associated with infrequent appearance of T and B lymphocytes, or neutrophil infiltration. Five days after infection with Adeno-beta 2-AR, the total beta-AR density increased six-fold (67.8 +/- 3.4 v 397.0 +/- 155.5 fmol/mg protein, n = 5, P < 0.01); isoproterenol-induced vasorelaxation at transmural pressures from 10-110/mmHg increased (P < 0.01) compared to arteries exposed to control virus (empty adenovirus), n = 4; and isoproterenol-stimulated cAMP production was increased by 65% (n = 5). Thus, adenoviral-mediated delivery of beta 2-ARs into large artery walls results in enhanced beta-AR-mediated vasorelaxation via augmentation in cAMP levels in vascular smooth muscle cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-2828
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1037-45
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9618244-Adenoviridae,
pubmed-meshheading:9618244-Animals,
pubmed-meshheading:9618244-Animals, Genetically Modified,
pubmed-meshheading:9618244-Carotid Arteries,
pubmed-meshheading:9618244-DNA, Viral,
pubmed-meshheading:9618244-Gene Expression Regulation,
pubmed-meshheading:9618244-Gene Transfer Techniques,
pubmed-meshheading:9618244-Genetic Code,
pubmed-meshheading:9618244-Genetic Vectors,
pubmed-meshheading:9618244-Humans,
pubmed-meshheading:9618244-Immunohistochemistry,
pubmed-meshheading:9618244-Muscle, Smooth, Vascular,
pubmed-meshheading:9618244-Rats,
pubmed-meshheading:9618244-Rats, Sprague-Dawley,
pubmed-meshheading:9618244-Receptors, Adrenergic, beta-2,
pubmed-meshheading:9618244-Vasodilation,
pubmed-meshheading:9618244-beta-Galactosidase
|
pubmed:year |
1998
|
pubmed:articleTitle |
Enhanced vasorelaxation by overexpression of beta 2-adrenergic receptors in large arteries.
|
pubmed:affiliation |
Department of Surgery, Duke University, Durham, NC, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|